ELK4 and prostate carcinoma: In this cohort, we identify mirrored-subclonal copy-number aberrations in all 10 of these cases, including parallel amplification of ELK4 and SLC45A3 which comprise a chimeric transcript known to be related to cell proliferation in prostate cancer [52, 53].